Try our beta test site
1 study found for:    21810686 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR
Conditions: Skin Diseases;   Carcinoma, Squamous Cell
Intervention: Drug: cetuximab

Study has passed its completion date and status has not been verified in more than two years.